The effect of Iberogast on heartburn in patients with functional dyspepsia
- Conditions
- Heartburnpyrosis10017977
- Registration Number
- NL-OMON49070
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 18
* Age above 18
* A history of dyspepsia (according to the Rome IV criteria) with heartburn
* Upper gastro-intestinal causes of the complaints excluded via gastroscopy with in addition an abdominal echography if deemed necessary by the physician
* Surgery of the GI tract other than appendectomy or cholecystectomy
* Use of any medication with a potential effect on gastrointestinal motility, secretion or sensitivity that cannot be stopped for the duration of the study (e.g. proton pump inhibitors, H2-blockers, antidepressants, prokinetics)
* Proton pump inhibitors must be stopped at least 7 days before start of the study
* Known Barrett*s oesophagus
* History of GI cancer
* Known allergy to one of the ingredients of Iberogast
* Known diabetes
* Severe and clinically unstable concomitant disease (e.g. liver, cardiovascular or lung disease, neurological or psychiatric disorders, cancer or AIDS and other endocrine disorders)
* Pregnancy (women will be asked if they are pregnant)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method